Filter
646
Text search:
treatment
disruptions
Featured
Recommendations
67
New Publications
99
Language
Document type
Studies & Reports
242
No document type
207
Guidelines
81
Strategic & Response Plan
54
Manuals
29
Fact sheets
15
Situation Updates
10
Training Material
5
Infographics
2
Brochures
1
Countries / Regions
Global
54
Ukraine
22
Liberia
19
Kenya
18
India
16
Africa
16
Sierra Leone
15
Western and Central Europe
15
Latin America and the Carribbean
14
Myanmar / Burma
12
Guinea
11
Syria
11
Ethiopia
10
Bangladesh
10
Yemen
10
East and Southern Africa
10
South–East Asia Region
10
Nigeria
8
Congo, Democratic Republic of
7
Somalia
7
South Sudan
7
Afghanistan
7
South Africa
7
West and Central Africa
7
Zimbabwe
6
Nepal
6
Pakistan
6
Malawi
6
Eastern Europe
5
Ghana
4
Uganda
4
Zambia
4
Rwanda
4
Mozambique
4
Middle East and North Africa
4
Senegal
3
USA
3
Cameroon
3
Haiti
3
Philippines
3
Sudan
3
Central African Republic
3
Namibia
3
Sri Lanka
3
Eastern Europe and Central Asia
3
Venezuela
3
Russia
3
Tanzania
2
Lesotho
2
Mexico
2
Asia
2
Moldova
2
Iran
2
Iraq
1
Jordan
1
Lebanon
1
Turkey
1
Egypt
1
Indonesia
1
Singapore
1
Peru
1
Brazil
1
Burundi
1
Colombia
1
Madagascar
1
Western Pacific Region
1
Bhutan
1
Palestine
1
North Korea
1
Djibouti
1
Canada
1
Timor Leste/ East Timor
1
Tajikistan
1
Lithuania
1
North America
1
Turkmenistan
1
Mauritius
1
Authors & Publishers
Publication Years
Category
Countries
195
Public Health
30
Clinical Guidelines
29
Women & Child Health
25
Key Resources
24
Capacity Building
9
Annual Report MEDBOX
1
Pharmacy & Technologies
1
Toolboxes
COVID-19
190
Mental Health
62
HIV
56
Conflict
42
Planetary Health
42
TB
27
Ebola
25
Natural Hazards
15
Rapid Response
14
Refugee
13
Global Health Education
12
NTDs
12
Health Financing Toolbox
12
NCDs
11
AMR
10
Caregiver
7
Specific Hazards
4
Cholera
3
Disability
2
Pharmacy
2
South Sudan
1
Typhoon
1
Zika
1
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir
...
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
The purpose of this field guide is to provide comprehensive information on planning and implementing high-quality3 SIAs for injectable vaccines and highlight the opportunities to strengthen RI and surveillance. The guide uses measles–rubella SIAs as the main example throughout, but the informatio
...
These WHO interim recommendations on the use of the Astra Zeneca – Oxford University AZD1222 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenc
...
A module from the suite of health service capacity assessments in the context of the COVID-19 pandemicINTERIM GUIDANCE5 February2021
The Community needs, perceptions and demand: community assessment toolcan be used by countries to conduct a rapid pulse survey of community health needs and perceptio
...
abridged version, March 2021
he study highlights the impacts of COVID-19 on women and men as gleaned from research conducted during 2020, as well as the Computer Assisted Telephonic Interviews (CATI) Rapid Gender Assessments (RGAs) executed by UN Women, UNFPA and partners in seven countries in the
...
Five years after a global commitment to Fast-Track the HIV response and end AIDS by 2030, the world is off track. A promise to build on the momentum created in the first decade of the twenty-first century by front-loading investment and accelerating HIV service provision has been fulfilled by too fe
...
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th
...
This report describes findings from a telephone survey with 1,323 people conducted in February 2021. The survey examined how people respond to public health and social measures (PHSMs) to prevent COVID-19. The sample is representative of households with access to a landline or cell phone, but does n
...
A wide range of potential enablers and barriers were identified for influencing progress for the scale-up of severe wasting services within national health systems. Findings were categorised according to the six pillars of WHO’s health system strengthening framework.
mnesty International’s annual report on the state of the world’s human rights in 2021, published in March 2022, shows that promises to “build back better” after the Covid-19 pandemic were little more than lip service. Hopes of global cooperation withered in the face of vaccine hoarding and c
...
In the wake of the Covid‑19 Pandemic, parts of the public health system at increased risk of reduced efficiency include healthcare services for women and children. This in turn could reverse all the progress achieved over the years in reducing maternal and child mortality. In th
...
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat
...
Background paper 10
The Independent Panel for Pandemic Preparedness and Response
May 2021
Background paper 11
The Independent Panel for Pandemic Preparedness and Response
May 2021
Recognizing the importance of the critical role of community health in disaster management, the Amref health Africa has
developed this operational guide to provide policy direction on COVID-19 response at community level. This guide has
been developed in collaboration with all the implementing cou
...
These WHO interim recommendations for use of the BBV152 COVAXIN vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been
...
Phil. Trans. R. Soc. B (2010) 365, 2959–2971; doi:10.1098/rstb.2010.0143.
Agricultural ecosystems provide humans with food, forage, bioenergy and pharmaceuticals and are essential to human wellbeing. These systems rely on ecosystem services provided by natural ecosystems, including pollination, b
...
